Increasing the options for effective migraine management

被引：8
作者：
Goadsby, PJ [1 ]
Olesen, J [1 ]
机构：
[1] UNIV COPENHAGEN,GLOSTRUP HOSP,DEPT NEUROL,DK-1168 COPENHAGEN,DENMARK
来源：
NEUROLOGY | 1997年 / 48卷 / 03期
关键词：
D O I：
10.1212/WNL.48.3_Suppl_3.1S
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S1 / S3
页数：3
相关论文
共 16 条
[1]   311C90: Patient profiles and typical case histories of migraine management [J].
Dowson, AJ .
NEUROLOGY, 1997, 48 (03) :S29-S33
[2]   Clinical safety of 311C90: Aggregated data from patients and volunteers to date [J].
Earl, NL .
EUROPEAN NEUROLOGY, 1996, 36 :8-12
[3]   IMPACT OF MIGRAINE AND TENSION-TYPE HEADACHE ON LIFE-STYLE, CONSULTING BEHAVIOR, AND MEDICATION USE - A CANADIAN POPULATION SURVEY [J].
EDMEADS, J ;
FINDLAY, H ;
TUGWELL, P ;
PRYSEPHILLIPS, W ;
NELSON, RF ;
MURRAY, TJ .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1993, 20 (02) :131-137
[4]   The clinical effectiveness of 311C90 in the acute treatment of migraine [J].
Ferrari, MD .
EUROPEAN NEUROLOGY, 1996, 36 :4-7
[5]   Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine [J].
Geraud, GEA .
EUROPEAN NEUROLOGY, 1996, 36 :24-27
[6]   Fortnightly review - Diagnosis and management of migraine [J].
Goadsby, PJ ;
Olesen, J .
BRITISH MEDICAL JOURNAL, 1996, 312 (7041) :1279-1283
[7]   Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)(1B/D) receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine? [J].
Goadsby, PJ ;
Hoskin, KL .
PAIN, 1996, 67 (2-3) :355-359
[8]   PERIPHERAL AND CENTRAL TRIGEMINOVASCULAR ACTIVATION IN CAT IS BLOCKED BY THE SEROTONIN (5HT)-1D RECEPTOR AGONIST 311C90 [J].
GOADSBY, PJ ;
EDVINSSON, L .
HEADACHE, 1994, 34 (07) :394-399
[9]   Burden of migraine - Societal costs and therapeutic opportunities [J].
Lipton, RB ;
Stewart, WF ;
vonKorff, M .
NEUROLOGY, 1997, 48 (03) :S4-S9
[10]   The doctor and the migraine patient: Improving compliance [J].
MacGregor, EA .
NEUROLOGY, 1997, 48 (03) :S16-S20
12